HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Custom Supplement Firm Shut Down: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

Warning letter and multiple form 483s fail to convince Custompax; Kellogg acquires RXBAR clean-label protein bars for $600m; NutraFuels used Blast Cap for products; and more news in brief.

You may also be interested in...



‘No B.S.’ In RxBar Package Front Claims, Advertising Self-Regulation Forum Finds

National Advertising Division sides with RxBar marketer in review of front-of-package list of ingredients and “No B.S.” statement challenged by Kind bars. NAD attorneys note food products commonly tout ingredients on labels without specifying relative prominence by weight, volume or other measures.

Post Expects Stronger Nutrition Business Value To Emerge On Its Own, Plans IPO

Planned IPO of 25% of shares in nutrition business targets unlocking value currently held down by Post's other units. Its competitors in cereal space as well as firms across broader food industry also may determine their acquired nutritional businesses could be higher valued operating separately.

Health, Beauty And Wellness News: Colorcon Iron Oxides Ready, Mannatech Loss From Taxes, Product Launches

Colorcon ready with synthetic iron oxide colors; Mannatech taxed to Q3 loss; LifeAid adds immunity formulation; Natural Alternatives adds SR CarnoSyn; Energy gum from Apollo; and non-cannabis CBD healing from Peak Health.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS121249

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel